IN RECENT NEWS

"One interesting observation is that the only company listed in all three functional categories is Gestalt Diagnostics. This must be a market-winning business strategy for Gestalt Diagnostics, as it is the only digital pathology company on the list above to grow rapidly enough to have made Inc. Magazine’s 2023 “5000 Fastest Growing Private Companies in America.” - The Dark Report, September, 2024


Dan Roark


Dan Roark

Chief Executive Officer

Mr. Roark is an experienced CEO, serial entrepreneur, active angel investor, and board member for technology businesses with experience in the life science industry and beyond. He is currently the CEO of Gestalt Diagnostics.


Previous roles include CEO & Founder of Matrical Bioscience in Spokane Washington, a business he sold in 2013 to Brooks Automation (Nasdaq: BRKS) and assumed the position of VP for Strategic Business and Market Development until 2016. 


He formerly was the VP & Founder of CCS Instruments based in Torrance, California, a business he sold in 1998 to Packard Bioscience (Nasdaq: PBSC) and subsequently into Perkin Elmer (NYSE: PKI), where he worked as the VP and General Manager until 2002. Prior to these roles, he worked at Tecan Group Ltd (SWX: TECN) in their US division based in Research Triangle Park, North Carolina, in Applications, Product, and Sales Management roles from 1988 to 1993.


His focus has encompassed the development and commercialization of innovative and patented industrial automation and consumables that have fueled several technologies, including the Human Genome Project, High Throughput Drug Screening at top-tier pharmaceutical and biotech companies, improved food crop breeding operations at leading agriculture companies, diagnostics biomarker testing for cancer and genetic disorders, blood bank screening for infectious diseases, and automated storage systems holding millions of chemical or biological samples used for new drug development and population genomics efforts for world-leading pharmaceutical and government-sponsored academic institutes and clinical hospitals. 


His leadership spans engineering, business operations, and market development efforts in the USA, Europe, Asia, and South America. 


He received B.S. degrees in Biochemistry and Chemical Engineering from Whitworth University in 1984 and Washington State University in 1987. He is an investor and mentor to startup companies and is affiliated with the Spokane Angel Alliance and KickStart III investment fund. He is an active outdoor enthusiast and likes to travel with family and friends. He has three grown children.


Share by: